Source: Annual Congress 2006 - Premature infants, bronchopulmonary dysplasia, prediction, aetiology and treatment
Disease area: Paediatric lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Martin, N. Stephanie, V. D. H. Katharina, C. M. Ana, P. Thomas, R. Wolfgang, K. A. Michael (Erlangen, Germany). Aerosolized IL-1β receptor antgonist: potential prevention of bronchopulmonary dysplasia?. Eur Respir J 2006; 28: Suppl. 50, 2169

Member's Comments

No comment yet.

Related content which might interest you: Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia. Source: International Congress 2017 – Infant lung disease: physiology, assessment and novel therapies  Year: 2017 P16 in bronchopulmonary dysplasia: Early determinant of respiratory disease? Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Pathogenesis of bronchopulmonary dysplasia Source: Eur Respir Monogr 2021; 92: 50-67 Year: 2021 Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020 Year: 2020 Transglutaminase 2: a new player in bronchopulmonary dysplasia? Source: Eur Respir J 2014; 44: 109-121 Year: 2014 Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine Source: Eur Respir J 2013; 41: 966-973 Year: 2013 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Neonatal resuscitation and respiratory support in prevention of bronchopulmonary dysplasia Source: Breathe 2011; 8: 14-23 Year: 2011 LATE-BREAKING ABSTRACT: Retinoids modulate TGF-β signalling in the lung through betaglycan and SMAD3: implications for retinoid use in bronchopulmonary dysplasia Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Treating allergic bronchopulmonary aspergillosis: the way forward Source: Eur Respir J 2016; 47: 385-387 Year: 2016 Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia Source: Eur Respir J 2009; 33: 861-870 Year: 2009 Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Prediction of bronchopulmonary dysplasia Source: Annual Congress 2009 - Neonatal respiratory disorders Year: 2009 Bronchopulmonary dysplasia as a cause of pulmonary hypertension Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life Year: 2020 Late Breaking Abstract - The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia Source: Eur Respir J, 59 (2) 2002248; 10.1183/13993003.02248-2020 Year: 2022 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014